Mrs Kathy Dodgson

Kathy is currently the Director of Biology at Aurelia Bioscience Ltd. She was one of the co-founders of Aurelia Bioscience, a biology-based contract research organisation (CRO), with Dr Gary Allenby in 2011. The company was acquired by Charnwood Molecular Ltd a chemistry CRO in 2021 and now offers integrated drug discovery to clients.
Kathy has a degree in Biochemistry and an MSc in Neuropharmacology. She has been involved in drug discovery for almost 30 years and has held a number of positions at AstraZeneca and prior to that at SmithKline Beecham. She has spent nearly 15 years in assay development and high throughput screening groups dedicated to supporting a number of disease areas including respiratory and inflammation and neuroscience. She is passionate about data and delivering the best assay for a drug discovery project.